NLS Algeta

Acquisition - March 6, 2014

Bayer completes voluntary takeover offer for Algeta

The Bayer Group has completed the voluntary takeover offer for Norwegian pharmaceutical company Algeta. According to a statement from Bayer, the payment of the offer price has been made to Algeta’s shareholders who accepted the takeover offer and, at the same time, the 43,131,641 tendered shares have been transferred to Bayer. As a result, Bayer […]

Acquisition - December 20, 2013

Bayer buys Algeta

Bayer plans to acquire Norwegian pharmaceutical company Algeta. The Bayer Group plans to further strengthen its oncology portfolio with the acquisition of Norwegian pharmaceutical company Algeta ASA, Oslo, according to a press release. Bayer has already collaborated with Algeta to develop and commercialize the cancer drug Xofigo. The planned acquisition would give Bayer full control […]

Drug Development Pharma - December 13, 2013

Bayer granted marketing authorization in Norway for prostate cancer treatment

Bayer HealthCare announced recently that the company has received the marketing approval for Xofigo by the Norwegian Medicines Agency. Xofigo (radium Ra 223 dichloride) has been developed by Algeta. In September 2009, the two companies signed an agreement for the further development and commercialization of radium-223. Xofigo is produced in Norway at the Institute for Energy Technology (IFE) at […]

Drug Development Pharma - November 18, 2013

Algeta & Bayer granted EU marketing authorization

Algeta and Bayer have received marketing authorisation from the European Commission for Xofigo for the treatment of prostrate cancer patients with  bone metastases. According to Oslo Cancer Cluster, the marketing authorization provides approval for the commercialization of Xofigo in all 28 countries of the EU, and in Norway, Iceland and Liechtenstein following national approval. The decision […]

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.